February 10, 2018 - By Adrian Erickson
Investors sentiment increased to 1.3 in 2017 Q3. Its up 0.12, from 1.18 in 2017Q2. It is positive, as 19 investors sold LifePoint Health, Inc. shares while 61 reduced holdings. 31 funds opened positions while 73 raised stakes. 40.50 million shares or 0.54% more from 40.28 million shares in 2017Q2 were reported.
First Advsr Ltd Partnership invested in 0.05% or 310,568 shares. 8,900 were reported by Highland Ltd Partnership. Parametrica Mngmt holds 0.12% or 4,873 shares in its portfolio. Chicago Equity Prtn Ltd Company holds 11,590 shares or 0.02% of its portfolio. Price T Rowe Associates Md reported 0.01% in LifePoint Health, Inc. (NASDAQ:LPNT). Old Mutual Customised Solutions (Proprietary) reported 2,400 shares stake. Commonwealth Of Pennsylvania Pub School Empls Retrmt Sys holds 5,852 shares or 0% of its portfolio. Citadel Advsr Limited Liability Corp stated it has 0.01% of its portfolio in LifePoint Health, Inc. (NASDAQ:LPNT). Dean Cap Mgmt reported 67,143 shares. Guggenheim Ltd Liability reported 63,159 shares. Moreover, Parkside Bancorp & Tru has 0.01% invested in LifePoint Health, Inc. (NASDAQ:LPNT). Us National Bank & Trust De owns 1,906 shares or 0% of their US portfolio. Ahl Prtn Ltd Liability Partnership holds 79,065 shares or 0.08% of its portfolio. Royal Bank Of Canada holds 0% of its portfolio in LifePoint Health, Inc. (NASDAQ:LPNT) for 42,003 shares. Hsbc Public Limited Liability Corporation invested 0% in LifePoint Health, Inc. (NASDAQ:LPNT).
The New American Century Investment Management Inc Holding in Lifepoint Health, Inc
American Century Investment Management Inc reported SC 13G/A form with the SEC for Lifepoint Health, Inc. Access it here: 000005238818000038. As reported by American Century Investment Management Inc, the filler owns 10.83% or 4,267,475 shares of the Health Care–company.
Lifepoint Health, Inc stake is new for [reportingPerson]. Date of activity: December 31, 2017. This shows American Century Investment Management Inc’s positive view for Lifepoint Health, Inc.
Lifepoint Health, Inc Institutional Sentiment
Filings show 266 investors own Lifepoint Health, Inc. The ownership in Q3 2015 is very high, at Infinity of the outstanding shares. This is increased by 1799978. 38201937 were owned by these investors. 35 funds opened new Lifepoint Health, Inc stakes, 108 increased positions. There were 31 that closed positions and 86 reduced them.
3 investors had the stock in their top 10. Some are: .
Anders Hallberg And Carl Bennet Healthinvest Partners Ab is an investor bullish on Lifepoint Health, Inc, owning 316430 shares as of Q3 2015 for 13.27% of its portfolio. Thomson Horstmann & Bryant Inc owns 20720 shares or 0.14% of its portfolio. KY Regent Investment Management Llc have 0.14% of its portfolio for 3510 shares. Further, Ronald Blue & Company Llc reported stake worth 0.07% of its portfolio. The KY Barr E S & Co owns 3600 shares. Lifepoint Health, Inc is 0.03% of its portfolio.
LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities. Its services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services and pediatric services, and in some of its hospitals, the Company offers specialized services, such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. It provides outpatient services, such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy.
SEC Form 13G.
Analysts await LifePoint Health, Inc. (NASDAQ:LPNT) to report earnings on February, 16. They expect $0.82 EPS, down 24.77 % or $0.27 from last year’s $1.09 per share. LPNT’s profit will be $32.32M for 14.50 P/E if the $0.82 EPS becomes a reality. After $0.80 actual EPS reported by LifePoint Health, Inc. for the previous quarter, Wall Street now forecasts 2.50 % EPS growth.
The stock increased 1.49% or $0.7 during the last trading session, reaching $47.55. About 461,612 shares traded. LifePoint Health, Inc. (NASDAQ:LPNT) has declined 5.01% since February 10, 2017 and is downtrending. It has underperformed by 21.71% the S&P500.
LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. The company has market cap of $1.87 billion. The Company’s hospitals offer a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric services, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. It has a 11.26 P/E ratio. The company's hospitals also provide various outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy.
LifePoint Health, Inc. (NASDAQ:LPNT) Ratings Coverage
Among 24 analysts covering Lifepoint Hospitals (NASDAQ:LPNT), 5 have Buy rating, 3 Sell and 16 Hold. Therefore 21% are positive. Lifepoint Hospitals has $107 highest and $45 lowest target. $64.05’s average target is 34.70% above currents $47.55 stock price. Lifepoint Hospitals had 55 analyst reports since August 4, 2015 according to SRatingsIntel. As per Monday, October 30, the company rating was downgraded by Raymond James. SunTrust maintained it with “Hold” rating and $60.0 target in Friday, October 13 report. The firm has “Hold” rating by Mizuho given on Friday, October 27. As per Tuesday, February 16, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating by Mizuho given on Monday, August 3. The stock of LifePoint Health, Inc. (NASDAQ:LPNT) has “Outperform” rating given on Wednesday, December 16 by Credit Suisse. The rating was maintained by Mizuho with “Neutral” on Tuesday, February 21. Mizuho maintained LifePoint Health, Inc. (NASDAQ:LPNT) rating on Monday, May 2. Mizuho has “Neutral” rating and $61.50 target. The company was downgraded on Wednesday, January 20 by Goldman Sachs. The rating was maintained by BMO Capital Markets with “Market Perform” on Monday, October 30.
More important recent LifePoint Health, Inc. (NASDAQ:LPNT) news were published by: Seekingalpha.com which released: “LifePoint Health (LPNT) Q2 2017 Results – Earnings Call Transcript” on August 01, 2017, also Globenewswire.com published article titled: “LifePoint Health To Broadcast Its Fourth Quarter And Year-End 2017 Conference …”, Businesswire.com published: “LifePoint Health Reports Third Quarter 2017 Results” on October 27, 2017. More interesting news about LifePoint Health, Inc. (NASDAQ:LPNT) was released by: Businesswire.com and their article: “LifePoint Health Completes Sale of Rockdale Medical Center” with publication date: October 02, 2017.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.